Prof Christopher McDevitt

Professor Christopher McDevitt is an internationally recognised bacteriologist whose research has transformed our understanding of the role of metal ions in infection and immunity. He is a leading global expert in his field (>100 publications; >$19M grant funding; 4 patent families), and his work has led to the discovery and patenting of ionophore compounds as breakers of bacterial antibiotic resistance. He leads a laboratory within the Peter Doherty Institute for Infection and Immunity, where he also serves as co-lead of the Bacterial and Parasitic Infections Theme and Co-Director of Research for the School of Biomedical Sciences, University of Melbourne.

Over the past 4 years, his research has focused on translating this fundamental discovery into new therapeutic applications. Prof. McDevitt’s translational work is currently focused on developing new therapeutics for the treatment of community-acquired bacterial pneumonia. His work is supported by the global non-profit CARB-X and the Australian funding agencies the NHMRC and the Australian Economic Accelerator.

LinkedIn: Christopher McDevitt